THE
ARCHIVES

A look at what the new research really shows about Ozempic-style drugs and the biology of getting older — and where the honest answer is still "we don't know yet." A drug developed to lower blood sugar has turned out to protect the heart, the kidneys, and possibly the brain, in real human trials, not just in theory. That track record has longevity researchers asking a bigger question: are these drugs treating a bunch of separate diseases, or are they nudging the aging process

Rapamycin is the only pharmacological agent proven to reproducibly extend mammalian lifespan across independent labs. This evidence-based executive brief synthesizes 8 peer-reviewed studies — including the 2025 PEARL trial, the first placebo-controlled human healthspan trial — covering mechanism, dosing, monitoring, and safety for precision aging medicine.